
ãçå®ã¯ããæçœã«ãªãã€ã€ãããïŒ COVID mRNAã¯ã¯ãã³ã®äžæåæ¢ãæ±ããæ°ããªæ»èªä»ãç ç©¶ã®èè
å èšäºã¯ãã¡ããã/Click here to read the original article.
äžå®å šãªããŒã¿ããæ·±å»ãªå®å šæ§ã®æžå¿µãããããŠæœåšçãªé·æçãªã¹ã¯ã«åºã¥ããæ»èªãåããæ°ããç ç©¶ã®èè ã¯ããã¡ã€ã¶ãŒç€Ÿã®COVID-19ã¯ã¯ãã³ã® ãæäœé ãã®äžæåæ¢ãå§åããŠããã
mRNAã¯ã¯ãã³COVID-19ã®ã¢ã©ããªã¢ã ãæ±ããæ°ããªæ»èªä»ãç ç©¶ãçºè¡šãããå ¬è¡è¡çåœå±ã«å¯Ÿãã確å®ãªå®å šæ§ç ç©¶ãè¡ããããŸã§äºé²æ¥çš®ã®äžæåæ¢ãæ±ãã声ãé«ãŸã£ãŠããã
Journal of American Physicians and Surgeonsèªã®2024幎å¬å·ã«æ²èŒããããã®ç ç©¶ã¯ããã¡ã€ã¶ãŒç€Ÿãšãã€ãªããã¯ç€Ÿã®COVID-19ã¯ã¯ãã³ãšããŒã¹ã¿ãŒã®ããŒã¿ãåæãããã®ã§ãããèè ãã¯ããæäœã§ã ãä¿å¥åœå±ã¯äºé²æ¥çš®ãäžæåæ¢ãã¹ãã ãšçµè«ã¥ããã
äžå®å šãªããŒã¿ããæ·±å»ãªå®å šæ§ã®æžå¿µãããããŠæœåšçãªé·æçãªã¹ã¯ã«åºã¥ããèè ãã¯ãã¡ã€ã¶ãŒïŒãã€ãªã³ããã¯ç€Ÿã®COVID-19 modRNAïŒä¿®é£ŸRNAïŒã¯ã¯ãã³ã®äžæåæ¢ãå§åããŠããã
財å£ã®åµèšè ã§ããããŒã¿ãŒã»ããã«ããŒå士ã¯ããã®ç ç©¶ã®èè ã®äžäººã§ããã
ç ç©¶ã«ããã°ããã¡ã€ã¶ãŒïŒãã€ãªã€ã³ããã¯ã®COVID-19泚å°ã¯éºäŒåæ²»çã§ããããåŸæ¥ã®ã¯ã¯ãã³ãšèª€ã£ãŠåé¡ãããŠãããããŸããæ¯æ§è©Šéšãçºããæ§è©Šéšã®äžè¶³ãèšåºè©Šéšã®äžåãèŠå¶åœå±ã®ç£ç£äžè¡ãå±ããæ³šå°ã«å«ãŸããã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãšè質ããç²åã«é¢ããå®å šæ§ã®æžå¿µãæµ®ã圫ãã«ãªã£ãã
ããã³ãããã¯ã®åæã«ãç§ãã¡ãä»ã®ç§åŠå£äœã¯ãmRNA泚å°ã®äžæ¢ãæ¿åºæ©é¢ã«æ±ããŠããŸããããããããã®ãã³ã«ç¡èŠããããããå€ãã®èšŒæ ãèç©ãããã«ã€ããŠãçå®ãæããã«ãªãã€ã€ãããŸãããšããã®ç ç©¶ã®äž»å·çè ã§ãããã£ãªããã»Rã»ãªãŒã«ããã£ãŒã«ãå士ã¯èšãã
ã¢ã©ããªã¢ã ãæ±ããææ°ã®å£°ã¯ããããªãå·ã®å€ç§å»ç·é·ãç±³åœå»åž«å€ç§å»åäŒãCOVIDå«çãæ±ããå»åž«ãã¡ãå¥åº·ã®èªç±ãæ±ããã¢ã¡ãªã«äººãã¡ãäžçä¿å¥åè°äŒãªã©ãmRNA COVID-19ã¯ã¯ãã³ã®äžæ¢ãæ¯æããç§åŠè ãå£äœã®ãªã¹ãã«å ãã£ãã
ã¢ã€ããå·ã®ä¿å¥å§å¡äŒã¯10æãå®å šæ§ãžã®æžå¿µããã30ã«æã®èšºçæã§ã®COVID-19ã¯ã¯ãã³ã®æäŸãäžæ¢ããããšã決å®ããããŸãåæãã¹ãããã¢æ¿åºã¯ãå±éºãªãmRNAã¯ã¯ãã³ã®çŠæ¢ãææ¡ããå ±åæžãçºè¡šããã
11æ29æ¥ã«ãCell Host & Microbeãèªã«çºè¡šãããå¥ã®ç ç©¶ã§ã¯ãè¡æ¶²è³é¢éã«ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãæç¶çã«ååšãããšãé倧ãªç¥çµé害ãåŒãèµ·ããå¯èœæ§ãããããšã倿ããã
ãã«ã·ã£ãŒã¯ããã£ãã§ã³ããŒãçŽã«ããèªã£ãŠããïŒ
ãã¹ãã€ã¯ã»ãããã€ã³ã¯ããããèåšç³»ã«ãã¡ãŒãžãäžããçæ¯ç©è³ªã§ããã¹ãã€ã¯ã»ãããã€ã³ã¯ãå·å®³ãè² ã£ãäººãæ»äº¡ãã人ã®è³ãå¯è ãå¿èãè¡æ¶²ããçŽæ¥æ€åºãããã®ã§ãã¯ã¯ãã³ã«é¢é£ããæ»äº¡ãéç¯€ãªæå®³äºè±¡ãšçµã³ã€ããããšãã§ããŸããã
ãã³ãã³å€§åŠã»ã³ãã»ãžã§ãŒãžææïŒè «çåŠïŒã®ã¢ã³ã¬ã¹ã»ãã«ã°ãªãŒã·ã¥å士ã¯ãããã£ãã§ã³ããŒãçŽã«å¯Ÿãã2ã€ã®æ°ããç ç©¶ã®ããããããéèŽæ»æ§ãŠã€ã«ã¹ã«å¯ŸããmRNAã¯ã¯ãã³ã®å³æäžæ¢ãæ£åœåããã®ã«ååã§ããããšèªã£ãã
ãã©ã¡ãã®ç ç©¶ããã¯ã¯ãã³æ¥çš®åŸã«é節ãªç¥çµçŸæ£ãæ¥éãªçŽåçã«ç§»è¡ãã人ãå¢ããŠããããšãè£ä»ããŠããŸãããšãã«ã°ãªãŒã·ã¥ã¯èšãã
äžçä¿å¥åè°äŒã®éå¶å§å¡äŒã®ã¡ã³ããŒã§ããã¯ãªã¹ããã»ãããå士ã¯ãããã£ãã§ã³ããŒãçŽã«å¯Ÿãããã®ç 究㯠ã人é¡ã®4åã®3ã«å¯ŸããéºäŒåæ²»çå®éšã®ç¶ç¶ããç§åŠçã«ãé埳çã«ã容èªã§ããªãæ¬ é¥ãæã€ããšãææãããäž»èŠãªåŽé¢ã®éåžžã«éèŠãªèŠçŽã§ãã ããšèªã£ãã
å ¬è¡è¡çæ©é¢ã¯ã¯ã¯ãã³ã®ãªã¹ã¯ã«æ³šæãæããªãããšãéžãã
Journal of American Physicians and Surgeonsèªã®ç ç©¶ã«ããã°ãCOVID-19泚å°ã¯ã¯ã¯ãã³ãšããŠåé¡ãããã¹ãã§ã¯ãªãã£ããšããã
ãCOVID-19ã®modRNAã¯ã¯ãã³ã¯éºäŒåæ²»ç補åãšããŠåé¡ãããªãããçã®ãããªéæææ§çŸæ£ã«å¯ŸããmRNAã¯ã¯ãã³ã¯mRNAã¯ã¯ãã³ãšããŠåé¡ããããéºäŒåæ²»ç補åãšããŠåé¡ãããã
ãã®ç ç©¶ã¯ãã¯ã¯ãã³ãšéºäŒåæ²»ç補åã§ã¯èŠå¶èŠä»¶ãç°ãªãããããã®åºå¥ã¯éèŠã§ãããšããŠããã
ãéºäŒåæ²»ç補åã®è£œé æ¥è ã«ã¯ã以äžã®ããšãèŠå¶èŠä»¶ãšãªã£ãŠããã
ãããããã¡ã€ã¶ãŒã»ãã€ãªã€ã³ããã¯ã®BNT162b2ïŒCOVID-19ã¯ã¯ãã³ïŒã¯ãåŸæ¥ã®ã¯ã¯ãã³ãšèª€ã£ãŠåé¡ãããããããã®ãããªããšã¯ãªãã£ãã
ãã®ç ç©¶ã§ã¯ãèšåºè©Šéšäžã®æ¬ é¥ãææããŠããããã«ã·ã£ãŒæ°ã«ããã°ãèšåºè©Šéšã§ã¯ãå人ã§ç£çãããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®éãã°ãã€ãã®ãããªéèŠãªèŠçŽ ãæž¬å®ã§ããªãã£ãããæåã®èšåºè©Šéšã§ãã©ã»ãçŸ€ãæ©æã«ç²æ€åããããé·æã®å®å šæ§ãšæå¹æ§ããŒã¿ã®å®å šæ§ãæãªããã ããšããã
ãã®ç ç©¶ã¯ãŸãããã¡ã€ã¶ãŒã»ãã€ãªNTããã¯ã®æåã®åžè²©åŸå ±åã®æç¹ã§ ãäžæ ããšåé¡ãããããããã¯å埩ããŠããªãæ°åäººã®æ£è ã«å ãããã¡ã€ã¶ãŒã»ãã€ãªNTããã¯ã®COVID-19泚å°ã®å°å ¥åŸ3ã¶æã§1,223äººã®æ»äº¡ãšãã ãé«ãæ»äº¡ç ããææããã
調æ»ã«ããã°
ãå»çä»å ¥åŸã®ãã®ãããªé«ãæ»äº¡çã¯ãä»ã®å»è¬åã§ããã°å³åº§ã«åžå Žããåãé€ãããã§ãããããããã£ãŠãçåãæããããããïŒ ãªãmodRNAã¯ã¯ãã³ã¯äœ¿çšããç¶ããã®ãïŒã
ãã¡ã€ã¶ãŒç€Ÿã¯ãŸãããã¹ãã€ã¯ã¿ã³ãã¯è³ªãšLNPïŒè質ããç²åïŒã害ãããããå¯èœæ§ãããã«ãããããããéºäŒæ¯æ§è©Šéšãçºçæ§è©Šéšã宿œããªãã£ãããšãã«ã·ã£ãŒã¯æžããŠããã
ãBNT162b2ãéºäŒæ¯æ§ãçºçæ§ãæã€ãšã¯èããããªãããã³ãŒããããã¹ãã€ã¯ã¿ã³ãã¯è³ªãç£çãããããåŸã£ãŠããããã®ç ç©¶ã¯å®æœãããã¹ãã§ãã£ããããããè¡ãããªãã£ãã
ãã®ç ç©¶ã§ã¯ãŸãããã¡ã€ã¶ãŒã»ãã€ãªãã³ããã¯ã ããŠã£ã¹ã¿ãŒãã³ ãã©ããã䜿ã£ãŠæ¯æ§åŠçç ç©¶ãè¡ã£ãããšã«ãèšåããŠããã
ãæ¯æ§åŠçç ç©¶ã®æšæºçãªæé ã¯ã2ã€ã®çš®ïŒ1ã€ã¯ãã£æ¯é¡ããã1ã€ã¯ãã£æ¯é¡ä»¥å€ã®çš®ïŒã䜿çšããããšã§ããã
ãéçã®ããºãã¯ããã«ææããå°ãªããšã55çš®é¡ã®ç åäœãæã£ãŠããã
Children's Health Defenseã®äžçŽç ç©¶å¡ã§ããã«ãŒã«ã»ãžã£ããããŠã¹ããŒå士ã¯ãã¯ã¯ãã³ã®æ¯æ§è©Šéšã«ã©ããã䜿ãããããšã¯ãè峿·±ãããšè¿°ã¹ãããã¯ã¯ãã³ã®äž»ãªæ©èœã¯ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãçæããããšã§ããããã®ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªã¯ã©ããã®ACE2ã¬ã»ãã¿ãŒã«ã¯çµåããŸããã
ãã®ç ç©¶ã¯ãŸããç±³åœé£åå»è¬åå±ïŒFDAïŒãå«ãèŠå¶åœå±ã®å€±æãæµ®ã圫ãã«ããã
ã2021幎2æãŸã§ã«ããã¡ã€ã¶ãŒïŒãã€ãªããã¯ç€ŸãFDAãããã®è£œåãé倧ãªå±éºæ§ãã¯ããã§ããããšããã§ã«èªèããŠãããã¯ã¯ãã³ã«é¢é£ããå¯äœçšãVAERSïŒã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒã«èšé²ããã€ã€ãã£ãã
ãªãŒã«ããã£ãŒã«ãã¯ãã¬ã¬ã·ãŒã¡ãã£ã¢ãã¯ã¯ãã³ã®å¯äœçšã軜èŠããã®ã¯ã瀟äŒçãçµç¹çå§åã«ãããã®ã ãšããããå ¬è¡è¡çæ©é¢ã¯ãç§åŠçã«é©åãªæ £è¡ãæ¡çšããç§åŠçã«å¥å šãªèŠå¶ææžãçºè¡ããããšãã§ããã¯ãã§ãããããã圌ãã¯ããããªãã£ãã
ãã«ã·ã£ãŒã¯ããã£ãã§ã³ããŒãèªã«å¯Ÿãããç±³åœã§ã¯VAERSã«å ±åãããCOVID-19ã¯ã¯ãã³é¢é£ã®æ»äº¡äŸã19,104ä»¶ãã ããšèªã£ããããã«æ¯ã¹ãŠããéå»ã«ã¯ããã¿ã·ãŒã«ãã¯ã¯ãã³ã¯ããã15äŸã®è žéç©çäŸã§åžå Žããæé€ããããã圌ã¯ãå ¬è¡è¡çæ©é¢ã®äžäœçºã ãåºç¯ãªèŠå¶ã®è ãã®ããã«ããã
ãããã§ã®ãã€ã³ãã¯ããããã®åœ±é¿ã®ã¡ã«ããºã ãæããã«ãªã£ããšããããšã§ãããããã£ãŠããããã®æå®³äºè±¡ã¯ ãæœåšç㪠ããã®ã§ã¯ãªããçŸå®ã«ååšãããã®ãªã®ã§ããmRNAã¯ã¯ãã³ã®é·æçãªå¹æã«ã€ããŠã¯ããŸã ããã£ãŠããªãããšã念é ã«çœ®ããŠãã ãããã
ãã®ç ç©¶ã®éèŠãªçŠç¹ã¯ãã¯ã¯ãã³æ¥çš®åŸã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãšLNPã®äœå ååžã§ãã£ããSubstackã§Hulscherã¯æ¬¡ã®ããã«æžããŠããã"ãã¡ã€ã¶ãŒç¬èªã®çäœå ååžããŒã¿ã§ã¯ãè質ããç²åïŒãšmodRNAïŒã¯èèãèŸèãåµå·£ãå¯è ãå«ãå šèº«ã«åºãååžããŠãããã
ãããã¯ã3幎çµã£ãä»ã§ããããã®éºäŒåæ²»çã«ãã£ãŠäœå ã§ææ¯ãªã¹ãã€ã¯ã¿ã³ãã¯è³ªãçæãããéã¯ããããªãããšè¿°ã¹ãããããããã以äžã«å¿é ãªã®ã¯ãç§ãã¡ã®äœå ã§ãã€ãŸã§çæãããã®ããããã«æªãããšã«ãéºäŒåã«çæããã°ã©ã ãã€ã³ã¹ããŒã«ãããåŸãçæãããªããªãã®ãã©ãããããããªãããšã§ãã
ãã«ã·ã£ãŒæ°ã«ããã°ãã¯ã¯ãã³è£œé æ¥è ã¯è²¬ä»»ãçŸã«ããã®ãããªæèŠãå ±åããææ¬²ããªãããŠãããšã®ããšã§ããããã«ã·ã£ãŒæ°ã¯ãã責任ã®ä¿è·ã享åããŠããããšãããããã®ãããªå€§èŠæš¡ãªå®å šæ§ã®æžå¿µãç¡èŠããŠãã ããšè¿°ã¹ãã
ãã¹ãŠã®mRNA泚å°ã«ã¢ã©ããªã¢ã ãèšããã¹ã
Cell Host & Microbeã®ç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ããç¥çµåŠçæå·ã«çŠç¹ãåœãŠããããSubstackã«æ²èŒãããç ç©¶ã®èŠçŽã§ãã«ã·ã£ãŒã¯ãèè ã㯠ãè³å¢çéšã«æç¶ããã¹ãã€ã¯ã¿ã³ãã¯è³ªãCOVID-19ã®æ°žç¶çãªç¥çµåŠçåŸéºçã«å¯äžããŠããå¯èœæ§ããããšçµè«ã¥ãã ããšè¿°ã¹ãŠããã
ãã¹ãã€ã¯ã¿ã³ãã¯è³ªãæ³šå ¥ããã ãã§ãè³æ¢å¡ãå€å·æ§è³æå·ã¢ãã«ããŠã¹ã«ãããŠãç¥çµççã»ã»ã»äžå®æ§è¡åãèªçºããè»¢åž°ãæªåãããã®ã«ååã§ãã£ã"ã
CHDã®ããŒãã»ãµã€ãšã³ãã£ãã£ãã¯ã»ãªãã£ãµãŒã§ãããã©ã€ã¢ã³ã»ããã«ãŒå士ã¯ããã®çºèŠã¯ãç¹ã«æ³šç®ãã¹ããã®ã§ããã
ããã®ããšã¯ãçºè²äžã®èå ããªãæ¯èŠªã®COVID-19泚å°ã«ãã£ãŠåºçåã«ã¹ãã€ã¯èçœã«æŽé²ãããã®ããšããçåãæãããããã®ã§ããããŸããã©ããã®ç ç©¶ã«ãããŠèªéçã«äŒŒã衚çŸåãèå ã«èŠãããããšã®èª¬æã«ããªãããšããã«ãŒæ°ã¯èªã£ãã
ãããããã®ç ç©¶ã®èè ã¯ãCOVID-19ã¯ã¯ãã³ã¯äœå ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ååšãæžå°ããããšã䞻匵ããŠããããã¯ã¯ãã³æ¥çš®ã¯ããŠã¹ææåŸã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®èç©ãæžå°ãããããé€å»ã¯ããªãã£ãã
ä»ã®ç§åŠè ãã¡ã¯ãããã®äž»åŒµã«çåãåãããããã«ãŒã«ããã°ããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ç£çã«ã€ãªããäºé²æ³šå°ãããŒã¹ã¿ãŒã6ã¶æä»¥äžã«ããã£ãŠäœåºŠãåãããšããäºå®ãèæ ®ããã°ãè³å ã«ã¹ãã€ã¯ã¿ã³ãã¯è³ªãèç©ããæ©äŒã¯ããã®ãããªäžååãªç ç©¶ãããã¯ããã«å€ã ããšã®ããšã§ããã
ã¡ãã£ã·ãã«ã»ã²ããã¯ã¹ã®åµèšè ã§ããã±ãã³ã»ããã«ãŒãã³ã¯ãmRNAã¯ã¯ãã³ã«SV40 DNAãæ··å ¥ããŠããããšãåããŠçªãæ¢ããç§åŠè ã§ããã圌ã¯ãDefenderãçŽã«ãããã®ãããªè«æã«ããã¯ã¯ãã³æ¥çš®ã®èšè¿°ã¯ãåžžã«æççã«åãæ¢ããªããã°ãªããªã ããšèªã£ãŠããã
ããã«ãŒãã³ã¯ããã®ç ç©¶ã§äœ¿çšãããããŠã¹ã¯ã人éã®å¹³åæäžéã®160åã®éã®ã¯ã¯ãã³ãæäžãããããšãææãããããç«å Žãéã§ããã®è«æãã¯ã¯ãã³ããã®äºæ ãæªåããããšäž»åŒµããããšããŠãã圌ãã¯ããŒã¿ãããã®ãããªè£ä»ãã®ä¹ããé£èºãããããšã¯ãªãã ãã ããšè¿°ã¹ãã
ããã«ãŒæ°ã¯ãããã¯COVID-19ã¯ã¯ãã³ã®ããŒã¹ã¿ãŒæäžãè€æ°ååããå¿ èŠããããããããã®ãããªäžååãªç ç©¶ããããè³å ã«ã¹ãã€ã¯ã¿ã³ãã¯è³ªãèç©ãããæ©äŒãã¯ããã«å€ããªã ããšææããã
Hulscheræ°ã«ããã°ããã®ç ç©¶ã®åçã«ã¯ãã¯ã¯ãã³æ¥çš®ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ååšãæžå°ããããšããçµè«ã¯å«ãŸããŠããªãã£ãã
ããã®åã£ãã¯ã¯ãã³æ¥çš®ã®é ã¯ãããããæ»èªããã»ã¹ãééããããã«ä»ãå ããããã ãã§ãããããç¥çµæ¯æ§ãæã€ã¹ãã€ã¯ã¿ã³ãã¯è³ªã倧éã«ã³ãŒãããmRNAãæ³šå°ããããšãæçã§ãããšããã®ã¯ãè«ççã«çãéã£ãŠããªãã
ãã¹ãŠã®mRNA ãã¯ã¯ãã³ ãã¯ãææ¯ãªå€æ¥æåãç£çããããã«ãæ§ã ãªèåšç³»ã®çްèããã€ãžã£ãã¯ããã®ã§ãåæ§ã«æ²æšãªå®å šæ§ãããã¡ã€ã«ãæã€å¯èœæ§ãé«ãããããã£ãŠããã¹ãŠã®mRNA泚å°ã¯ã¢ã©ããªã¢ã ã§ããã¹ãã§ãããšãã«ã·ã£ãŒã¯ä»ãå ããã